Archbow Consulting announced Justine Hughes has been promoted to EVP of principal operations while Honora Gabriel and Rob ...

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

A damaging trial failure in December wiped 70% off the share price of BioAge Labs, a US biopharma developing therapeutic ...

Madrigal Pharmaceuticals Inc. (MDGL) is our top conservative biotech recommendation for 2025. The company is in the sweet spot and de-risked with the first FDA-approved drug for chronic liver ...

Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 7 includes Village Super Market, MARA Holdings, ...

The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

Analysts at StockNews.com started coverage on shares of Old Point Financial (NASDAQ:OPOF – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “hold” rating on the ...

U.S. Bancorp, a prominent financial institution, has disclosed in an 8-K filing with the Securities and Exchange Commission the appointment of Gunjan Kedia as the President and Chief Executive Officer ...

TransCon CNP matches BioMarin's Voxzogo for achondroplasia with plans for regulatory filings in 2025, showing potential for ...